English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 27, 2026

FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Researchers find dengue virus infects memory B cells, revealing new immune evasion strategy
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Randomized trial reduces alcohol use in Zambian refugee settlement, study finds
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

AI identifies combination therapy that may improve survival in advanced rectal cancer patients
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Gossamer regains rights to lung drug after Phase 3 trial setback and plans FDA submission
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

FDA schedules advisory committee meetings amid leadership changes and industry questions
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Researchers at IIT Gandhinagar develop injectable hydrogel for faster deep wound healing
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Summit and Merck face regulatory challenges for China-first cancer drugs

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes